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 Abstract 
Purpose: To identify predictors of favourable changes to postprandial insulin and glucose levels 
in response to interrupting prolonged sitting time with standing or light intensity physical 
activity. Methods: Data were combined from four similarly designed randomised acute cross-
over trials (n=129; BMI range 19.6 to 44.6kg/m2; South Asian=31.0%; dysglycaemia=27.1%). 
Treatments included: prolonged sitting (6.5hours) or prolonged sitting broken-up with either 
standing or light-intensity physical activity (5 minutes every 30 minutes). Time-averaged 
postprandial responses for insulin and glucose were calculated for each treatment (mean±95% 
CI). Mutually adjusted interaction terms were used to examine whether anthropometric (BMI), 
demographic (age, sex, ethnicity (white European vs. South Asian)) and a cardiometabolic 
variable (HOMA-IR) modified responses. Results: Postprandial insulin and glucose were 
reduced when individuals interrupted prolonged sitting with bouts of light physical activity, but 
not with standing. Reductions in time-averaged postprandial insulin were more pronounced if 
individuals were South Asian compared with white European (-18.9mU/L (-23.5%) vs. -
8.2mU/L (-9.3%)), female compared to male (-15.0mU/L (-21.2%) vs. -12.1mU/L (-17.6%)) or 
had a BMI ≥27.2kg/m2 (-20.9mU/L (-22.9%) vs. -8.7mU/L (-18.2%)). Similarly, being female (-
0.4mmol/L (-0.6mmol/L, -0.2mmol/L) (-6.8%) vs. –0.1mmol/L (-0.3mmol/L, 1mmol/L) (-
1.7%)) or having a BMI ≥27.2kg/m2 (-0.4mmol/L (-0.6mmol/L, -0.2mmol/L) (-6.7%) vs. –
0.2mmol/L (-0.4mmol/L, 0.0mmol/L) (-3.4%)) modified the postprandial glucose response. No 
significant interactions were found for HOMA-IR or age. Conclusion: Being female, South 
Asian or having a higher BMI, all predicted greater reductions in postprandial insulin, while 
being female and having a higher BMI predicted greater reductions in postprandial glucose when 
sitting was interrupted with light physical activity. These results could help to guide personalised 
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 interventions in high-risk participants for whom breaking prolonged sitting time with light 
activity may yield the greatest therapeutic potential. Keywords: postprandial, physical activity, 
sedentary behaviour, risk factors, insulin, glucose 
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 Introduction 
Postprandial hyperglycaemia plays a significant role in the development of cardiovascular 
disease (CVD) in people with type 2 diabetes mellitus (T2DM) (1). The postprandial phase is 
characterised by a rapid and large increase in blood glucose and insulin levels. Observational 
evidence suggests that postprandial hyperglycaemia, even in the absence of fasting 
hyperglycaemia, is associated with higher risks of future cardiometabolic disease (2, 3). 
Similarly, a hyperinsulinaemic response is closely associated with a number of CVD and T2DM 
related outcomes (4). Therefore, if these links are in part causal, establishing effective and 
pragmatic interventions that reduce post‐meal hyperglycaemic and hyperinsulinaemic excursions 
could be important therapeutic targets for the prevention of T2DM and CVD, particularly as 
individuals spend a large proportion of the day in a postprandial state (5).  
 
Physical activity is known to enhance health and improve postprandial hyperglycaemia (6). 
Current physical activity guidelines recommend that adults engage in at least ≥150 minutes of 
moderate intensity physical activity or ≥75 minutes of vigorous activity and 2–3 resistance 
exercise sessions per week (7). In addition, current physical activity guidelines now include 
specific recommendations to reduce and interrupt prolonged sitting (6, 8). These guidelines have 
been informed by emerging research suggesting that sitting time per se is an independent risk 
factor for cardiometabolic morbidity and mortality (9, 10). Over recent years, epidemiological 
research has been complemented by acute experimental studies showing that breaking up bouts 
of prolonged sitting with standing or light intensity activity elicits significant benefits on markers 
of metabolic health
 
(11-15).  
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 These results are important as light intensity activities are behaviourally more ubiquitous than 
moderate to vigorous physical activity (MVPA) and may therefore be appealing interventional 
targets in the promotion of metabolic health, whilst also being more culturally acceptable to high 
risk groups (e.g. South Asian women). However, the inter-individual variability in the 
effectiveness of such interventions is likely to be large. For example, previous experimental 
research has shown that the magnitude of postprandial dysglycaemia in response to prolonged 
sitting and the subsequent reduction following breaks may differ considerably according to 
ethnicity or the degree of underlying insulin resistance (13, 16). 
 
Therefore, in order to ensure future T2DM prevention strategies are stratified and targeted at 
those who could derive the greatest benefit, it is necessary to determine the factors that may 
predict a favourable response to breaking up prolonged sitting with a low intensity 
intervention.As such, the aim was to determine whether commonly measured demographic, 
anthropometric or clinical factors are associated with the postprandial insulin and glucose 
response when breaking up prolonged sitting, with short bouts of either standing or physical 
activity, at a light intensity.   
 
Methods 
Study design 
We performed a pooled analysis of data collected from 129 individuals across four separate 
acute, randomised, crossover experimental studies conducted within the Leicester Diabetes 
Centre (University of Leicester) (n=99) and the University of Glasgow (n=30), UK (2015-2018); 
all of which followed the same protocols and standard operating procedures for data collection 
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 and the same treatment methodology of breaking sitting time with 5 minutes of standing or light 
physical activity every 30 minutes (see Figure, Supplemental Digital Content 1, protocols and 
standard operating procedures for data collection, http://links.lww.com/MSS/B865). The 
research design and methods have been published in detail elsewhere (11-14). Briefly, 
participants were recruited from studies previously conducted within the Leicester Diabetes 
Centre (ACUTE, ARMING HEALTH, STAND UP) or from the public via strategic placement 
and distribution of promotional materials (STAND UP, FIT2SIT). Detailed inclusion and 
exclusion criteria can be found in Supplementary Digital Content Table 1 (see Table, 
Supplemental Digital Content 2, Inclusion and exclusion criteria, 
http://links.lww.com/MSS/B867).  
 
Participants attended up to four separate visits to their corresponding centre. One to two weeks 
after an initial familiarisation visit, participants were randomised to the following treatment 
conditions: 1) prolonged sitting (6.5 hours; plus 60 minute steady state); 2) prolonged sitting 
broken up with standing for 5 minutes every 30 minutes or 3) prolonged sitting broken up with 
physical activity (either walking or arm ergometry) for 5 minutes every 30 minutes. As an acute 
bout of physical activity may enhance insulin sensitivity for up to 48 hours, we used a minimum 
wash-out period of 7 days between each condition.  
 
All studies were registered with clinicaltrials.gov (ACUTE: NCT02135172; STAND UP: 
NCT02453204; ARMING HEALTH: NCT02909894; FIT2SIT: NCT02493309). Written 
informed consent was obtained from all eligible participants and the individual studies had full 
ethical and governance approval. 
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 Participants 
In total, 147 participants were randomised. Causes of drop out between familiarisation and 
randomisation are detailed in Figure 1. A further 18 individuals were excluded after 
randomisation: due to cessation of the venous cannula line which resulted in less than 50% of 
data collection (n=11); illness (n=2); inability to tolerate the standardised meal (n=2), unable to 
commit time (n=2); or a change in personal circumstance (n=1). This left 129 participants that 
were included in the analysis.  
 
Familiarisation visit 
Before participating in the experimental protocol, participants visited the Leicester Diabetes 
Centre or University of Glasgow for a familiarisation visit in which they were accustomed to the 
required power output for the arm ergometry or walking speed (self-perceived light intensity) . 
Participants were instructed to walk at a pace they felt was comfortable and registered between 
10 and 12 on the Borg RPE scale (17). Body mass (Tanita TBE 611, Tanita, West Drayton, UK) 
and height were measured, to the nearest 0.1kg and 0.5cm respectively. Information regarding 
demographic variables (age and ethnicity) was collected following an interview administered 
protocol. For the ACUTE and ARMING HEALTH studies, non-diabetic hyperglycaemia was 
defined as 2-h post challenge glucose ≥7.8 mmol/L to <11.1 mmol/L after a standard oral 
glucose tolerance test or HbA1c 39–46 mmol/mol (5.7%-6.4%) inclusive (18), identified within 
the 12 months prior to the initial invitation letter being sent (see Table, Supplemental Digital 
Content 1, inclusion and exclusion criteria, http://links.lww.com/MSS/B866). 
 
 
AC
CE
PT
ED
 Experimental treatment overview 
Participants were asked to record all food and drink consumed the day before the first 
experimental condition. They were then asked to replicate this diet before subsequent treatments. 
Participants were also requested to avoid alcohol, caffeine and any MVPA for two days prior to 
each experimental condition (11-14).  
 
Participants arrived at the laboratory after a 10-hour fast and had a cannula fitted into an 
accessible arm vein and then asked to sit quietly for 60 minutes. A fasting blood sample (9ml) 
was then taken (time point: 0 h) for the quantification of insulin and glucose. Participants were 
provided with a standardised breakfast that was typical of a westernised diet. Across the four 
studies, this consisted of 45.0±12.7% carbohydrate, 40.7±11.5% fat and 14.3±1.3% protein of 
energy intake (11-14). The time taken to consume the meal (≤15 minutes) was recorded and 
replicated in subsequent conditions. Blood was sampled at 30, 60, 120 and 180 minutes 
postprandially. Lunch, with an identical nutrient composition to breakfast, was consumed at 180 
minutes with blood samples taken again at 30, 60, 120 and 210 minutes postprandially (see 
Figure, Supplemental Digital Content 1, protocols for treatment conditions, 
http://links.lww.com/MSS/B866). The research staff supervised participants throughout each 
study cycle to ensure full compliance with the trial protocols. Participants consumed water ad 
libitum during the first of the experimental conditions and were asked to replicate the volume 
ingested in subsequent conditions.  
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 Experimental conditions:  
Figure, Supplemental Digital Content 1 highlights the experimental conditions undertaken during 
each of the four included studies (see Figure, Supplemental Digital Content 1, protocols for 
treatment conditions, http://links.lww.com/MSS/B866). 
 
Prolonged sitting (6.5 hours) (ACUTE, STAND UP, ARMING HEALTH, FIT2SIT) 
All four studies included a prolonged sitting condition (11-14), where walking and standing was 
restricted (lavatory visits were conducted via a wheelchair). Participants sat in a designated room 
equipped with a chair, desk, laptop and access to books and magazines.  
 
Standing: Sitting (total 5.5 hours) + Standing (total 60 minutes) (ACUTE, STAND UP) 
Two studies employed a standing protocol (13, 14) which followed the same procedure as the 
sitting condition, except that participants were instructed to break their sitting time by standing 
close to their chair for 5 minutes, every 30 minutes. Individuals were asked to stand in the same, 
fixed position. In total, individuals accumulated 12 bouts (60 minutes) of standing. 
 
Physical activity 
Walking: Sitting (total 5.5 hours) + walking (total 60 minutes) (ACUTE, STAND UP, FIT2SIT) 
Three studies employed a walking protocol (12-14) which was similar to the standing condition, 
but participants conducted 5-minute bouts of walking at a light intensity. Walking speed ranged 
from 1.5 to 4.4 km/h. In total, individuals accumulated 12 bouts (60 minutes) of walking. For the 
ACUTE and FIT2SIT trials, the walking breaks were carried out on a treadmill (Spazio Forma 
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 Folding Treadmill/ Excite 700, TechnoGym U.K. Ltd., Bracknell, U.K). For the STAND UP trial 
participants were instructed to walk up and down a marked track in the laboratory. 
 
Arm ergometry: Sitting (total 5.5 hours) + arm ergometry (total 60 minutes) (ARMING 
HEALTH) 
One study employed upper body physical activity through arm ergometry (11). The power output 
(watts) necessary to elicit the desired energy expenditure during the main experimental condition 
(equivalent to walking at 3km/h) was established during the familiarisation visit (11). The 
subsequent power output was implemented for 5 minutes, every 30 minutes. In total, individuals 
accumulated 12 bouts (60 minutes) of arm ergometry. 
 
Cardiometabolic variables 
For the studies conducted solely at the Leicester Diabetes Centre (11, 12, 14), all samples were 
analysed within the same location. Plasma glucose was determined using standard enzymatic 
techniques with commercially available kits (Beckman, High Wycombe, UK) and using stable 
methodology standardized to external quality assurance reference values. Insulin and glucose 
samples underwent centrifugation to separate plasma within 15 minutes of collection. Plasma 
derived from insulin was stored at -80
o
C and analysed at the end of data collection using an 
enzyme immuno-assay (Mercodia, Uppsala, Sweden). Each sample was analysed in duplicate to 
ensure reliability of readings. Sample values with ≥20% variability were reanalysed.  
 
All samples for STAND UP (13)
  
were analysed at the
 
University of Glasgow. Glucose was 
analysed using clinically validated automated biochemistry platforms (c311, Roche Diagnostics, 
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 Burgess Hill, UK). Insulin and glucose samples underwent identical preparation (centrifugation 
and storage) to the Leicester samples and were measured with an equivalent immunoassay 
platform (e411, Roche Diagnostics, Burgess Hill, UK). The analysers were calibrated and quality 
controlled using the manufacturer’s materials. Coefficient of variation over two levels of controls 
was less than 3% for biochemistry assays and less than 6% for insulin.  
 
All measurements and analysis were undertaken by individuals blinded to experimental 
condition. 
 
Statistical analyses 
Missing outcome data for participants included in this analysis were imputed using a regression 
model with key predictor variables (baseline BMI, age, fasting values, ethnicity and treatment) 
for each time point and outcome. Imputation was used to correct for verification bias (19). 
Across all experimental conditions, 3.5% of data values (148/4248) were missing and imputed. 
 
Generalised estimating equations (GEE) with an exchangeable correlation matrix were used, 
considering repeated measures across treatments. Due to the right-skewed distributions of 
positive values, insulin was analysed using a gamma distribution with an identity link. Total area 
under the curve (AUC) was first calculated by applying the trapezium rule and time-averaged 
AUC (i.e. AUC divided by the 6.5 hours, to give an average postprandial response) was then 
used as a summary measure for postprandial insulin and glucose, which can be interpreted as the 
average glucose or insulin concentration (not including the initial 60 minute steady state). 
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) was calculated as fasting 
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 insulin (mU/L) x fasting glucose (mmol/L)/22.5, using baseline values. This model is commonly 
used as an index of insulin resistance and the validity of estimates in relation to gold standard 
measures has been examined in several epidemiological studies, in a wide variety of 
populations (20). 
 
All models included, as independent variables, study and treatment (sitting, standing, light 
physical activity), along with age (continuous), sex, ethnicity, HOMA-IR (continuous) and BMI 
(continuous). In addition, interaction terms with treatment were entered simultaneously into the 
same model to investigate whether the effect of treatment was modified by anthropometric 
(BMI), demographic (age, sex, ethnicity) or cardiometabolic (HOMA-IR) variables 
independently to the other factors. Significant interactions were then stratified by dichotomous 
categories or using the median split.  
 
To highlight the direction of significant interactions, modelling responses for insulin values were 
estimated in white European and South Asian males and females, aged 60, at BMI levels of 
25kg/m
2
 (normal), 30kg/m
2
 (overweight) and 35kg/m
2
 (obese).   
 
All data were analysed using SPSS (version 24.0).  A p-value of <0.05 was considered 
statistically significant for main effects and p<0.1 for interactions. Descriptive data are reported 
as mean (95% CI) in text and tables, unless otherwise stated.  
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 Sensitivity Analyses 
In order to aid interpretation and assess the robustness of the outcome, we investigated whether 
results were affected by removing the ARMING HEALTH participants (n=13), as this protocol 
did not involve a change in posture. Furthermore, to ascertain whether factors that were found to 
modify the treatment effect for postprandial responses were driven by higher control values 
(postprandial response during the sitting condition), we repeated the main analysis after further 
adjusting for the postprandial response to prolonged sitting (categorised as low, medium or high 
derived through tertiles). 
 
Results 
129 participants were included in this analysis. Table, Supplemental Digital Content 3 shows the 
baseline anthropometric, cardiometabolic and demographic information. There were no 
significant differences in BMI, age, fasting or HOMA-IR values between those who dropped out 
and those who were included in this analysis (see Table, Supplemental Digital Content 3, 
Metabolic, demographic and anthropometric characteristics, http://links.lww.com/MSS/B868). 
 
Overall treatment effect 
Table 1 displays the results for main effects of treatment. After adjustment for HOMA-IR, age, 
sex, BMI and ethnicity, the time-averaged insulin responses (reflecting average concentrations 
over the postprandial period) were 13.6mU/L ((95% CI) 9.5mU/L, 17.7mU/L) lower during light 
physical activity breaks compared with prolonged sitting. Similarly, time-averaged glucose 
responses were 0.3mmol/L (0.2mmol/L, 0.4mmol/L) lower in the light physical activity 
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 condition vs. prolonged sitting after adjustment for the same variables. There was no treatment 
effect for standing breaks compared to prolonged sitting for insulin or glucose.  
 
Impact of demographic (ethnicity, age, sex), anthropometric (BMI) and cardiometabolic 
(HOMA-IR) variables: Interaction and stratified analyses 
The results for interactions are presented in Table 1. Figure 2a, 2b and Table, Supplemental 
Digital Content 4 display the stratified analysis for both insulin and glucose (see Table, 
Supplemental Digital Content 4, stratified analysis for insulin and glucose responses during each 
treatment condition, http://links.lww.com/MSS/B869). 
 
Ethnicity 
There was an ethnicity x treatment interaction for insulin (p=<0.001) but not glucose (p=0.354). 
For South Asians, the insulin time-averaged response was 18.9mU/L (13.8mU/L, 24.1mU/L) 
(23.5%) lower during physical activity breaks compared to prolonged sitting, whereas for white 
Europeans the insulin response was 8.2mU/L (3.5mU/L, 13.0mU/L) (9.3%) lower.  
 
BMI 
Interactions were seen for both insulin and glucose (both p=<0.001). For those with a BMI above 
the median split (≥27.2kg/m2), the insulin response was reduced by 20.9mU/L (11.7mU/L, 
30.0mU/L) (22.9%) during physical activity breaks compared to prolonged sitting. Those with a 
BMI<27.2kg/m
2
 demonstrated an 8.7mU/L (4.7mU/L, 12.7mU/L) (18.2%) reduction in insulin. 
A similar pattern was observed for glucose, where those with a BMI≥27.2kg/m2 gained a greater 
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 metabolic benefit following regular light physical activity breaks [-0.4mmol/L (-0.6mmol/L, -
0.2mmol/L) (-6.7%) vs. –0.2mmol/L (-0.4mmol/L, 0.0mmol/L) (-3.4%)].  
 
Sex 
A sex x treatment interaction was seen for insulin (p=0.043) and glucose (p=0.018). For the 
insulin response, females reported a greater metabolic benefit when breaking prolonged sitting 
with light physical activity [-15.0mU/L (-20.0mU/L, -10.0mU/L, (-21.2%)], compared to males 
[-12.1mU/L (-15.9mU/L, -8.4mU/L) (-17.6%)].  For glucose, females also displayed a greater 
reduction than men when breaking up prolonged sitting with light physical activity [(-0.4mmol/L 
(-0.6mmol/L, -0.2mmol/L) (-6.8%) vs. –0.1mmol/L (-0.3mmol/L, 1mmol/L) (-1.7%)]. 
 
Age 
There was no age x treatment interaction for insulin (p=0.149) or glucose (p=0.811).  
 
HOMA-IR 
There was no HOMA-IR x treatment interaction for insulin (p=0.240) or glucose (p=0.549).  
 
Predicted response 
Figure 3 and Table, Supplemental Digital Content 5 display how the predicted average difference 
between conditions for insulin changes as BMI increases for white European and South Asian, 
males and females, using given values for HOMA-IR (2.0) and age (60 years) (see Table, 
Supplemental Digital Content 5, redicted insulin response stratified by sex, ethnic and BMI 
categories for a 60-year-old individual, http://links.lww.com/MSS/B870). The results 
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 demonstrate that the average blood insulin response for a 60 year old, South Asian female with a 
BMI of 35kg/m
2
 and HOMA-IR of 2.0, decreased from 90.3mU/L to 58.2mU/L (35.2% 
reduction) (from prolonged sitting to light physical activity breaks, respectively), whereas 
average responses for a 60 year old, white European male, with a BMI of 25kg/m
2
 decreased 
from 49.5mU/L to 45.1mU/L (8.9% reduction).  
 
Predicted insulin responses were calculated from the following, fully adjusted regression 
equation, derived from a single GEE model. The light-intensity physical activity condition 
includes a summation of the beta-coefficients for main outcomes and treatment x outcome 
interactions: 
 
Insulin response during prolonged sitting =-16.327 + (-0.146*age) + (1.953*BMI) + 
(12.871*HOMA-IR) + (18.789 if South Asian) + (2.457 if female). 
 
Insulin responses during the light-intensity physical activity condition = 12.344 + (-0.111*age) + 
(0.547*BMI) + (12.871*HOMA-IR) + (8.068 if South Asian) + (-0.414 if female). 
 
Sensitivity Analyses 
The significance levels were largely unaffected when the ARMING HEALTH study was 
removed from the analysis. These results are presented in Table, Supplemental Digital Content 6 
[see, Table, Supplemental Digital Content 6, time-averaged area under the curve values (main 
effects) and outcome x interaction terms for insulin and glucose responses during each treatment 
condition – with the ARMING HEALTH participants removed (n=13), 
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 http://links.lww.com/MSS/B871]. Furthermore, the pattern of results remained similar when 
additionally adjusting for the category of postprandial response during prolonged sitting. For 
insulin, the ethnicity (p=0.002) and BMI (p=0.021) x treatment interactions remained. However, 
the sex x treatment interaction was attenuated (p=0.124). For glucose, both the BMI (p=0.002) 
and sex (p=0.021) x treatment interactions persisted.  
  
Discussion 
This analysis demonstrates that laboratory studies regularly breaking prolonged sitting with 
light-intensity physical activity lead to acutely lower postprandial insulin and glucose levels. 
Furthermore, it illustrates that demographic (sex, ethnicity) and anthropometric (BMI) variables 
modify the insulin and glucose responses, with the results for ethnicity, BMI and sex (glucose 
only) being independent of the postprandial response to prolonged sitting. For insulin, being 
female, South Asian or having a higher BMI resulted in the greatest metabolic benefit when 
breaking prolonged sitting. For example, regular light intensity physical activity breaks for a 60-
year-old South Asian female, with a BMI of 35kg/m
2
would lower insulin levels by more than a 
third (35.2%). In contrast, breaking prolonged sitting through regular physical activity breaks in 
a 60-year old white European male with a BMI of 25kg/m
2
 would only lower insulin levels by 
8.9%.  
 
These data build on previous work reporting potential differences in the postprandial response 
between white Europeans and South Asians and those with varying levels of underlying 
glycaemia (13). It has been well established that South Asians have a higher risk of 
cardiometabolic disease than white Europeans (21, 22), potentially driven by differences in body 
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 composition (23). For example, South Asians develop T2DM up to 12 years earlier than white 
Europeans and at lower BMI levels (24). Our results further illustrate that, a 60 year old South 
Asian female, with a BMI of 25kg/m
2 
would have a similar postprandial response during 
prolonged sitting to that of a 60-year-old white European female, with a BMI of 35kg/m
2 
(70.7mU/L vs. 71.5mU/L, respectively). Such findings are also broadly consistent with previous 
cross-sectional epidemiological data, which demonstrated that South Asians with a BMI of 
22.6kg/m
2
 have equivalent prevalence of dysglycaemia to white Europeans with a BMI of 
30kg/m
2 
(25). Nevertheless, despite South Asians having greater metabolic dysfunction, the 
results of our analysis suggest that they are likely to receive the greater absolute benefit per dose 
of light activity, which is also consistent with previous epidemiological and experimental work 
(13, 26).  
 
In this analysis, females were also shown to derive the greatest metabolic benefit when breaking 
prolonged sitting with bouts of light physical activity. The sex difference observed in our results 
are broadly consistent with previous epidemiological work, which has demonstrated that 
associations between sedentary behaviour, total self-reported weekday sitting time and TV 
viewing time (a surrogate marker of total sitting time) with markers of cardiometabolic health are 
stronger in females (27, 28).  
 
As all of the significant variables (sex, ethnicity, BMI) are central components to a number of 
inexpensive and easy to use risk assessment tools (29, 30), these variables may be used to further 
guide the identification of participants for whom breaking prolonged sitting time may yield the 
greatest benefit. Similar to individualised targets for HbA1c, these findings may also compliment 
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 a precision medicine approach, whereby T2DM prevention and treatment take into account 
individual variability in response to breaking prolonged sitting.   
 
With such a low attainment of current physical activity guidelines (5-10% achieve 30 minutes 
per day of at least moderate-intensity physical activity, on at least 5 days per week based on 
accelerometer data) (31, 32), a reasonable goal may be to first break up sitting time with light 
intensity physical activity and then eventually progress to higher activity intensities. The 
intensity of light breaks in this analysis ranged from 1.5-4.4km/h, with no adverse events, 
suggesting that the individuals included in this analysis are able to tolerate small activity doses 
on a regular basis. This also includes the arm ergometry experimental condition, where 
participants remained in a seated posture throughout, thus offering a potential alternative strategy 
to breaking sitting time in wheelchair users or those with peripheral neuropathy. In addition, 
although the beneficial effects of physical activity are generally attributed to intensity (33), 
evidence from acute, experimental studies demonstrate that higher intensities with increasing 
frequency in breaks in prolonged sitting are not necessarily a synonym of better postprandial 
control (15, 34). Indeed, high and low intensities and frequencies in breaks, when matched for 
energy cost, produce similar effects on postprandial concentrations (34, 35). The exact timing of 
the onset of postprandial physical activity to break sitting time may also be important. The first 
bout of light physical activity in this analysis took place 30 minutes after the first meal 
(breakfast), which has been proposed as the optimal timing for post meal exercise as peak post 
meal values typically occur within 90 minutes (36). Initiating activity during this time window 
may blunt peak excursions, even when performed at very light intensities and in small doses 
(15). 
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 We found no change in the glucose or insulin postprandial values for the standing condition, 
which is consistent with other acute, experimental studies (37). Nevertheless, replacing sitting 
with standing may still yield other health benefits. For example, a recent randomised controlled 
trial demonstrated that a decrease in occupational sitting time (-83 minutes/workday vs. control) 
at 12 months had a positive impact on multiple subjective outcomes such as job performance, 
work engagement, occupational fatigue, sickness presenteeism, musculoskeletal problems and 
quality of life (38). Importantly, the time spent sitting was largely displaced with standing, as 
stepping time remained unchanged. 
 
The current analysis has strengths and limitations. We were able to provide rigorous estimates of 
the postprandial responses to breaking prolonged sitting, by using data combined from four 
laboratory‐based, randomised cross-over treatments that used the same experimental protocols. 
For example, meal timing, frequency of blood samples and duration and frequency of light 
physical activity breaks were identical across studies (see Figure, Supplemental Digital Content 
1, protocols for treatment conditions, http://links.lww.com/MSS/B866). This current analysis 
also displays a reasonable degree of heterogeneity as it includes both men and women, white 
Europeans and South Asians, as well as individuals of normal-weight and individuals with 
overweight/obesity, encompassing a broad continuum of postprandial responses. By their nature, 
the studies were proof of concept experimental studies and utilised protocols that may have 
limited population generalisability. Future studies should focus on whether the effects observed 
in this analysis are replicable under free living scenarios over a longer observation period. 
Furthermore, as there was no formal sample size calculation, p values are to be viewed with 
caution and in relation to the overall pattern of results. 
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 Conclusion 
The present findings suggest that standard demographic and anthropometric outcomes may 
predict the postprandial response to breaking up prolonged sitting with regular bouts of light 
intensity physical activity. Being female, South Asian or having a higher BMI, all predicted 
greater reductions in postprandial insulin, while being female and having a higher BMI predicted 
greater reduction in postprandial glucose. These results may be used to guide individualised 
tailored interventions in high risk participants for whom breaking prolonged sitting time could be 
a viable and effective prevention strategy.  
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 Figures 
Figure 1. Study CONSORT Diagram. 
 
Figure 2. Stratified analysis for insulin (A) and glucose (B) responses during each treatment 
condition. **p=<0.001, *p=<0.05 compared to the prolonged sitting. 
 
Figure 3. Predicted insulin response stratified by sex, ethnic and BMI categories for a 60-year-
old individual. 
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Table 1. Time-averaged area under the curve values (main effects and 95% CI) and outcome x interaction terms for insulin and glucose 
responses during each treatment condition 
 
Variable Sitting Standing Light Physical 
Activity 
Ethnicity x 
treatment 
Sex x 
treatment 
Age x 
treatment 
BMI x 
treatment 
HOMA-IR 
x treatment 
Insulin   
(mU/L) 
69.9 (63.6, 76.3) 75.9 (66.9, 84.9) 56.4 (50.7, 62.0)** <0.001 0.043 0.149 <0.001 0.240 
Glucose 
(mmol/L) 
5.9 (5.7, 6.1) 5.9 (5.6, 6.1) 5.6 (5.4, 5.8)** 0.354 0.018 0.811 <0.001 0.549 
Covariates to derive the estimated marginal means are fixed at the following values: Age= 63.3years; HOMA-IR=2.35; BMI=27.7kg/m
2
. Values 
displayed as time-averaged response (95% CI). 
**p=<0.001 compared to the prolonged sitting condition. 
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 SDC Table 1. Inclusion and exclusion criteria  
 STAND-UP ACUTE FIT2SIT ARMING HEALTH 
INCLUSION 
Aged 25-55 years   X  
Aged 50-75 years  X   
Aged 65-79 years X    
Aged 30-75 years    X 
Overweight or obese (BMI ≥27.5kg/m2 or ≥25kg/m2 if south Asian)  X  X 
BMI <30kg/m
2
   X  
Screen detected impaired glucose regulation  X  X 
Post-menopausal  X   
Able to walk X X X  
Ability to communicate in and understand English and to provide informed consent. X X X X 
EXCLUSION 
Undertaking regular purposeful exercise (≥150 minutes of moderate or ≥75 minutes 
of vigorous exercise per week) 
X X X X 
Known type 2 diabetes X X X X 
Known cardiovascular disease X  X X 
Steroid use X X X X 
Glucose lowering medication use X X X X 
Regular smoking habit   X X 
Pregnancy   X X 
Psychotic illness X X X X 
Psychological or neurological condition which limits participation in the study X X X X 
Hormone replacement medication  X   
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 SDC Table 2. Metabolic, demographic and anthropometric characteristics  
 
 ACUTE 
(n=22) 
STAND-UP 
(n=60) 
ARMING 
HEALTH 
(n=13) 
FIT2SIT 
(n=34) 
Overall 
(n=129) 
Age 66.7±4.8 70.0 ±4.9 66.5±6.0 40.0±9.0 63.6±13.6 
[range: 25 to 79] 
Sex (female) 22 (100) 29 (48) 7 (53.8) 18 (52.9) 76 (58.9) 
BMI (kg/m
2
) 32.9±4.7 26.9±3.9 33.9±3.8 24.5±3.0 27.8±4.9 
[range: 19.6 to 44.6] 
Ethnicity (white European) 20 (90.9) 30 (50) 13 (100) 26 (76.5) 89 (69.0) 
Fasting insulin (mU/L) 15.1±8.3 9.6±5.6 19.5±16.4 5.2±5.8 10.1±8.4 
[range: 0.4 to 74.1] 
Fasting glucose (mmol/L) 5.4±0.4 5.1±0.8 5.2±0.5 4.7±0.5 5.0±0.7 
[range: 2.1 to 7.9] 
HOMA-IR 3.6±2.1 2.2±1.5 4.6±3.9 1.0±1.2 2.4±2.0 
[range: 0.1 to 17.1] 
Non-diabetic hyperglycaemia 22 (100) 0 (0) 13 (100) 0 (0) 35 (27.1) 
Data presented as mean ± SD and [range], median (interquartile range) or number (column percentage)  
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 SDC Table 3. Stratified analysis for insulin and glucose responses during each treatment condition 
 
 Insulin (mU/L)  Glucose (mmol/L) 
Sitting Standing Light Physical 
Activity 
Sitting Standing Light Physical 
Activity 
BMI 
BMI <27.2kg/m
2
 45.0 (40.2. 49.8) 53.6 (44.8, 62.5) 36.8 (33.6, 40.0)** 5.8 (5.5, 6.1) 5.9 (5.6, 6.2) 5.6 (5.3, 5.9)* 
BMI ≥27.2kg/m2 91.6 (76.9, 106.3 96.4 (77.5, 115.3) 70.7 (59.5, 89.1)** 6.0 (5.7, 6.3) 5.8 (5.5, 6.1) 5.6 (5.3, 5.9)** 
Sex 
Male 68.7 (62.1, 75.3) 78.5 (67.4, 89.5) 56.6 (50.6, 62.5)** 5.9 (5.7, 6.1) 5.9 (5.5, 6.1) 5.8 (5.6, 6.0) 
Female 71.2 (64.4, 77.9) 73.4 (65.2, 81.7) 56.1 (50.5, 61.8)** 5.9 (5.6, 6.1) 5.8 (5.5, 6.1) 5.5 (5.3, 5.7)** 
Ethnicity 
White European 60.5 (54.3, 66.8) 63.7 (55.9, 71.4) 52.3 (47.0, 57.7)** - - - 
South Asian 79.3 (71.3, 87.4) 88.3 (75.5, 101.0) 60.4 (53.2, 67.6)** - - - 
- Covariates to derive the estimated marginal means for sex and ethnicity were fixed at the following values: Age=63.3years; HOMA-IR=2.35; 
BMI=27.7kg/m
2
.  
- For BMI <27.2kg/m
2
, the covariates to derive the estimated marginal means were fixed at the following values: Age=61.4years; HOMA-
IR=1.69; BMI=24.0 kg/m
2
. 
- For BMI ≥27.2kg/m2, the covariates to derive the estimated marginal means were fixed at the following values: Age=65.1years; HOMA-
IR=3.00; BMI=31.4 kg/m
2
. 
**p=<0.001, *p=<0.05 compared to the prolonged sitting. Values displayed as time-averaged response (95% CI). 
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 SDC Table 4. Predicted insulin response stratified by sex, ethnic and BMI categories for a 
60-year-old individual 
Ethnicity Age Sex BMI 
(kg/m
2
) 
HOMA-
IR 
Treatment Mean 
predicted 
insulin 
response 
(mU/L) 
South Asian 60 Female 25 2.0 Sitting 70.7 
white European 60 Female 25 2.0 Sitting 51.9 
South Asian 60 Female 30 2.0 Sitting 80.5 
white European 60 Female 30 2.0 Sitting 61.7 
South Asian 60 Female 35 2.0 Sitting 90.3 
white European 60 Female 35 2.0 Sitting 71.5 
South Asian 60 Female 25 2.0 Physical activity 52.8 
white European 60 Female 25 2.0 Physical activity 44.7 
South Asian 60 Female 30 2.0 Physical activity 55.5 
white European 60 Female 30 2.0 Physical activity 47.4 
South Asian 60 Female 35 2.0 Physical activity 58.2 
white European 60 Female 35 2.0 Physical activity 50.2 
South Asian 60 Male 25 2.0 Sitting 68.3 
white European 60 Male 25 2.0 Sitting 49.5 
South Asian 60 Male 30 2.0 Sitting 78.0 
white European 60 Male 30 2.0 Sitting 59.3 
South Asian 60 Male 35 2.0 Sitting 87.8 
white European 60 Male 35 2.0 Sitting 69.0 
South Asian 60 Male 25 2.0 Physical activity 53.2 
white European 60 Male 25 2.0 Physical activity 45.1 
South Asian 60 Male 30 2.0 Physical activity 55.9 
white European 60 Male 30 2.0 Physical activity 47.8 
South Asian 60 Male 35 2.0 Physical activity 58.6 
white European 60 Male 35 2.0 Physical activity 50.6 
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 SDC Table 5. Time-averaged area under the curve values (main effects) and outcome x interaction terms for insulin and glucose responses 
during each treatment condition – with the ARMING HEALTH participants removed (n=13) 
 
Variable Sitting Standing Light Physical 
Activity 
Ethnicity x 
treatment 
Sex x 
treatment 
Age x 
treatment 
BMI x 
treatment 
HOMA-IR 
x treatment 
Insulin   
(mU/L) 
60.1 (55.1, 65.1) 66.6 (58.7, 74.5) 46.9 (43.0, 50.8)** <0.001 0.056 0.150 0.001 0.353 
Glucose 
(mmol/L) 
5.9 (5.7, 6.1) 5.8 (5.5, 6.1) 5.6 (5.4, 5.8)** 0.488 0.008 0.768 0.001 0.434 
Covariates to derive the estimated marginal means are fixed at the following values: Age= 63.0years; HOMA-IR=2.15; BMI=27.1kg/m
2
. Values 
displayed as time-averaged response (95% CI). 
**p=≤0.001 compared to the prolonged sitting condition 
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